Cargando…

Parkinson’s disease as a systemic pathology

Detalles Bibliográficos
Autores principales:	Ezquerra, Mario, Martí, María-José, Fernández-Santiago, Rubén
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402515/ https://www.ncbi.nlm.nih.gov/pubmed/30745469 http://dx.doi.org/10.18632/aging.101824

Ejemplares similares

Whole-genome DNA hyper-methylation in iPSC-derived dopaminergic neurons from Parkinson’s disease patients
por: Fernández-Santiago, Rubén, et al.
Publicado: (2019)

Transcriptome analysis in LRRK2 and idiopathic Parkinson’s disease at different glucose levels
por: Fernández-Santiago, Rubén, et al.
Publicado: (2021)

Altered expression of the immunoregulatory ligand-receptor pair CD200-CD200R1 in the brain of Parkinson’s disease patients
por: Rabaneda-Lombarte, Neus, et al.
Publicado: (2022)

Accumulation of mitochondrial 7S DNA in idiopathic and LRRK2 associated Parkinson's disease
por: Podlesniy, Petar, et al.
Publicado: (2019)

Differential Phospho‐Signatures in Blood Cells Identify LRRK2 G2019S Carriers in Parkinson's Disease
por: Garrido, Alicia, et al.
Publicado: (2022)

Epigenetic Research of Neurodegenerative Disorders Using Patient iPSC-Based Models
por: Fernández-Santiago, Rubén, et al.
Publicado: (2016)

Mitochondrial and autophagic alterations in skin fibroblasts from Parkinson disease patients with Parkin mutations
por: González-Casacuberta, Ingrid, et al.
Publicado: (2019)

Differential serum microRNAs in premotor LRRK2 G2019S carriers from Parkinson’s disease
por: Soto, Marta, et al.
Publicado: (2023)

Exhaustion of mitochondrial and autophagic reserve may contribute to the development of LRRK2(G2019S)-Parkinson’s disease
por: Juárez-Flores, Diana Luz, et al.
Publicado: (2018)

Mitochondria: Key Organelle in Parkinson's Disease
por: Gómez-Sánchez, Rubén, et al.
Publicado: (2016)

Serum MicroRNAs Predict Isolated Rapid Eye Movement Sleep Behavior Disorder and Lewy Body Diseases
por: Soto, Marta, et al.
Publicado: (2022)

Regulatory rare variants of the dopaminergic gene ANKK1 as potential risk factors for Parkinson’s disease
por: Pérez-Santamarina, Estela, et al.
Publicado: (2021)

Nonmotor Symptoms in LRRK2 G2019S Associated Parkinson’s Disease
por: Gaig, Carles, et al.
Publicado: (2014)

Author Correction: Regulatory rare variants of the dopaminergic gene ANKK1 as potential risk factors for Parkinson’s disease
por: Pérez‑Santamarina, Estela, et al.
Publicado: (2022)

Putative Role of Red Wine Polyphenols against Brain Pathology in Alzheimer’s and Parkinson’s Disease
por: Caruana, Mario, et al.
Publicado: (2016)

Genetics of Parkinson's Disease and Other Diseases of the Extrapyramidal System
por: Dorszewska, Jolanta
Publicado: (2014)

Sex differences in Parkinson's Disease: An emerging health question
por: Philipe de Souza Ferreira, Luiz, et al.
Publicado: (2022)

Familial Parkinson's Disease/Parkinsonism
por: Tomiyama, Hiroyuki, et al.
Publicado: (2015)

Deep Brain Stimulation in Parkinson's Disease
por: Mehanna, Raja, et al.
Publicado: (2018)

Aberrant epigenome in iPSC‐derived dopaminergic neurons from Parkinson's disease patients
por: Fernández‐Santiago, Rubén, et al.
Publicado: (2015)

Disrupted Mitochondrial and Metabolic Plasticity Underlie Comorbidity between Age-Related and Degenerative Disorders as Parkinson Disease and Type 2 Diabetes Mellitus
por: Juárez-Flores, Diana Luz, et al.
Publicado: (2020)

Implication of Autophagy in Parkinson's Disease
por: González-Polo, Rosa Ana, et al.
Publicado: (2013)

A neurorestorative approach to Parkinson's disease
por: Diana, Giovanni, et al.
Publicado: (2017)

The sweet road to Parkinson’s disease
por: Renaud, Justine, et al.
Publicado: (2019)

Identifying the genetic components underlying the pathophysiology of movement disorders
por: Ezquerra, Mario, et al.
Publicado: (2011)

People with Parkinson’s as Partners for the Journal of Parkinson’s Disease
por: McFarthing, Kevin, et al.
Publicado: (2023)

Discovering the 3′ UTR-mediated regulation of alpha-synuclein
por: Marchese, Domenica, et al.
Publicado: (2017)

Gait in Parkinson's Disease
por: Martinez-Ramirez, Daniel, et al.
Publicado: (2019)

Rehabilitation and Parkinson's Disease
por: Earhart, Gammon M., et al.
Publicado: (2012)

Neuropsychiatry of Parkinson's Disease
por: Teixeira, Antonio L., et al.
Publicado: (2012)

Inflammation and Parkinson's Disease
por: Barcia, Carlos, et al.
Publicado: (2011)

Mitochondria and Parkinson's Disease
por: Simon, David K., et al.
Publicado: (2011)

Cannabidiol in Parkinson’s disease
por: Rieder, Carlos R.
Publicado: (2020)

Neurobiology of Parkinson’s Disease
por: Morelli, Micaela, et al.
Publicado: (2023)

The Renin-Angiotensin-Aldosterone System in Metabolic Diseases and Other Pathologies
por: Ortiz, Rudy M., et al.
Publicado: (2023)

Transcriptomic differences in MSA clinical variants
por: Pérez-Soriano, Alexandra, et al.
Publicado: (2020)

Tau Pathology in Parkinson's Disease
por: Zhang, Xue, et al.
Publicado: (2018)

Epidemiology of Parkinsonism and Parkinson's disease in Sub-Saharan Africa: Nigerian profile
por: Akinyemi, Rufus O
Publicado: (2012)

Nonmotor Symptoms of Parkinson's Disease
por: Rektorova, Irena, et al.
Publicado: (2011)

Communication Impairments in Parkinson's Disease
por: Murdoch, Bruce, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_klo2sb7a7groj0ak75ap36vact